These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11926124)

  • 1. Web alert. The chemistry of biological products.
    Cavalla D
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):189-90. PubMed ID: 11926124
    [No Abstract]   [Full Text] [Related]  

  • 2. Web alert. The chemistry of biological products.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):168-9. PubMed ID: 11378955
    [No Abstract]   [Full Text] [Related]  

  • 3. Web alert. The chemistry of biological products.
    Cavalla D
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):157-8. PubMed ID: 12669448
    [No Abstract]   [Full Text] [Related]  

  • 4. Web alert. The chemistry of biological processes.
    Cavalla D
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):607-8. PubMed ID: 14579509
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological effects of urotensin II].
    Zhang YG; Tang CS
    Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):59-61. PubMed ID: 12545780
    [No Abstract]   [Full Text] [Related]  

  • 6. A new ligand for the urotensin II receptor.
    Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
    Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High content drug screening and its application].
    Zhang L; Du GH
    Yao Xue Xue Bao; 2005 Jun; 40(6):486-90. PubMed ID: 16144310
    [No Abstract]   [Full Text] [Related]  

  • 8. Web alert. The chemistry of drug design and lead optimization.
    Cavalla D
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):473-4. PubMed ID: 12197305
    [No Abstract]   [Full Text] [Related]  

  • 9. The evolving role of natural products in drug discovery.
    Koehn FE; Carter GT
    Nat Rev Drug Discov; 2005 Mar; 4(3):206-20. PubMed ID: 15729362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulative effect of human urotensin-II on cardiovascular system.
    Zhou P; Li ZL; Tang CS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):566-8. PubMed ID: 12297490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Web alert. The chemistry of drug design and lead optimization.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):375-6. PubMed ID: 11727302
    [No Abstract]   [Full Text] [Related]  

  • 12. Web alert: patent information.
    Berrie MS
    Chem Biol; 1999 Nov; 6(11):R311-2. PubMed ID: 10660357
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay.
    Brkovic A; Hattenberger A; Kostenis E; Klabunde T; Flohr S; Kurz M; Bourgault S; Fournier A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1200-9. PubMed ID: 12807997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptidic ligands for peptide-activated G protein-coupled receptors.
    Blakeney JS; Reid RC; Le GT; Fairlie DP
    Chem Rev; 2007 Jul; 107(7):2960-3041. PubMed ID: 17622179
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
    Lescot E; Bureau R; Rault S
    Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic internet-based review of complementary and alternative medicine for glaucoma.
    Gunasekera V; Ernst E; Ezra DG
    Ophthalmology; 2008 Mar; 115(3):435-439.e2. PubMed ID: 17900696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico patent searching reveals a new cannabinoid receptor.
    Baker D; Pryce G; Davies WL; Hiley CR
    Trends Pharmacol Sci; 2006 Jan; 27(1):1-4. PubMed ID: 16318877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors.
    Behm DJ; Herold CL; Camarda V; Aiyar NV; Douglas SA
    Eur J Pharmacol; 2004 May; 492(2-3):113-6. PubMed ID: 15178353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotechs go generic: the same but different.
    Ledford H
    Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194
    [No Abstract]   [Full Text] [Related]  

  • 20. Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC).
    Balamurugan R; Dekker FJ; Waldmann H
    Mol Biosyst; 2005 May; 1(1):36-45. PubMed ID: 16880961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.